Rapid Dose Therapeutics Vaccine Delivery Study Receives Mitacs Accelerate Grant
Burlington, Ontario--(Newsfile Corp. - June 25, 2024) - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE is pleased to announce the recent award of a Mitacs Accelerate grant, with a value of $30,000 in May 2024 in addition to $55,000 in 2023, to continue the development of Thin Polymer Films for Vaccine Delivery Project, led by Prof. Alex Adronov, of McMaster University. This grant-funded research project aims to...
2024-06-25 7:15 AM EDT
Rapid Dose Provides Update on Common Share Private Placement
Burlington, Ontario--(Newsfile Corp. - June 19, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 8, 2024, regarding a proposed equity private placement financing (the "Financing"), the Company has received an extension from the Canadian Securities Exchange allowing it to close the Financing on or before August 8, 2024. This previously announced Financing contemplates an aggregate of up to $6,000,000 of gross...
2024-06-19 7:54 AM EDT
Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application
Burlington, Ontario--(Newsfile Corp. - May 29, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces its collaboration in the National Football League (NFL) – funded clinical trial program entitled "Naturally Produced Cannabinoids for Pain Management and Neuroprotection from Concussion and Participation in Contact Sports" led by Dr. J. Patrick Neary and researchers at the University of Regina. RDT will partake in a randomized, two-arm clinical study, which is...
2024-05-29 10:40 AM EDT
Rapid Dose Therapeutics and McMaster University's Incorporation of Loratadine-Cyclodextrin Complexes in Oral Thin Films for Rapid Drug Delivery
Burlington, Ontario--(Newsfile Corp. - May 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE in partnership with McMaster University ("McMaster") is pleased to announce the publication of the results of their collaborative research project titled "Incorporation of Loratadine-Cyclodextrin Complexes in Oral Thin Films ("OTF") for Rapid Drug Delivery" in the Journal of Pharmaceutical Sciences....
2024-05-22 8:00 AM EDT
Rapid Dose Therapeutics and Thrive Cannabis Sign MOU to Provide Quickstrip(TM) Oral Thin Strips Under a White Label Manufacturing Agreement
Burlington, Ontario--(Newsfile Corp. - March 13, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Memorandum of Understanding ("MOU") February 27, 2019 with THRIVE Cannabis ("THRIVE") providing THRIVE the rights to sell oral thin film strips with RDT's proprietary QuickStrip™ technology using cannabis distillates provided by...
2019-03-13 8:31 AM EDT
Rapid Dose Therapeutics Corp. Grants Stock Options
Burlington, Ontario--(Newsfile Corp. - March 11, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Corporation") announces the grant of options to directors, officers, eployess and consultants to purchase 4,526,000 common shares of the Corporation, exercisable at $0.82 per share at any time on or before March 11, 2024. The grants are subject to the terms of RDT's stock option plan. In accordance with securities regulatory requirements, any shares issued pursuant to the exercise...
2019-03-11 8:31 AM EDT
Rapid Dose Therapeutics Wins Summary Judgment Against CTT Pharmaceuticals. CTT's Case Is Dismissed
Burlington, Ontario--(Newsfile Corp. - March 5, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has been successful in obtaining a summary judgment against CTT Pharmaceutical Holdings, Inc. ("CTT") dismissing CTT's lawsuit against RDT. Justice E.M. Morgan of the Ontario Superior Court of Justice wrote in the Court's decision, "There is no...
2019-03-05 5:38 PM EST
Rapid Dose Therapeutics Corp. Announces Amalgamation with Its Wholly-Owned Subsidiary, Rapid Dose Therapeutics Inc.
Burlington, Ontario--(Newsfile Corp. - March 1, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Corporation") is pleased to announce the completion of a vertical amalgamation (the "Amalgamation") with its wholly-owned subsidiary, Rapid Dose Therapeutics Inc., pursuant to section 177 of the Business Corporations Act (Ontario). The Amalgamation did not require shareholder approval and was completed to simplify the corporate structure of RDT. No securities were issued in...
2019-03-01 4:50 PM EST
Rapid Dose Therapeutics Business Update
Burlington, Ontario--(Newsfile Corp. - February 26, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian bio-technology company focused on innovative drug delivery solutions, is pleased to provide a business update. RDT's proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral fast-dissolving drug delivery system for both nutraceutical and cannabis products. RDT continues its efforts to develop its business, including expanding the...
2019-02-26 8:40 AM EST
Rapid Dose Therapeutics Enters Into Advisory Agreement with Spinnaker Capital Markets
Burlington, Ontario--(Newsfile Corp. - February 14, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT") is pleased to announce that it has appointed Spinnaker Capital Markets Inc. ("Spinnaker") as its capital markets and investor relations advisor. Spinnaker is a Toronto-based advisory firm which provides public companies with an array of services tailored to raise capital, target and attract institutional and retail investors, increase shareholder value and focus on developing and...
2019-02-14 8:13 AM EST
Rapid Dose Therapeutics Announces Appointment of Dr. Gabriela Radulescu as Medical Director
Burlington, Ontario--(Newsfile Corp. - January 23, 2019) - Rapid Dose Therapeutics (CSE: DOSE) ("RDT") is pleased to announce the appointment of Dr. Gabriela Radulescu as Medical Director for RDT. Dr. Radulescu is a physician with 20 years of experience in the pharmaceutical industry. She brings to the RDT team strong strategic and operational medical leadership that will enhance the dialogue with pharmaceutical companies wanting to offer QuickStrip™ technology to their patient base. Dr....
2019-01-23 7:00 AM EST
Rapid Dose Therapeutics Announces Launch of Its Innovative QuickStrip(TM) Product to the Nevada Cannabis Market Through Brand Partnership with Flower One
Burlington, Ontario--(Newsfile Corp. - January 15, 2019) - Rapid Dose Therapeutics Inc. (CSE: DOSE) ("RDT") is pleased to announce its entered into a definitive agreement (the "Agreement") on January 10, 2019, with Flower One Holdings Inc. (CSE: FONE) (OTCQB: FLOOF)("Flower One") pursuant to which Flower One has been granted license to manufacture, distribute and sell RDT's QuickStrip™, an innovative, proprietary delivery technology for the cannabis market in Nevada. Flower One expects to...
2019-01-15 12:56 PM EST
Rapid Dose Therapeutics and Aphria to Deliver Innovative QuickStrip(TM) Technology to the German Cannabis Market
Ontario and Leamington, Ontario--(Newsfile Corp. - December 18, 2018) - Rapid Dose Therapeutics Inc. (CSE: DOSE) ("RDT" or the "Company") and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) announced today that they have expanded the scope of their previously announced agreement (the "Agreement"), executed on November 1, 2018 (see the Company's press release dated November 5, 2018), expanding the territory where Aphria has been granted exclusive preferred rights to license, manufacture,...
2018-12-18 7:44 AM EST
Rapid Dose Therapeutics Begins Trading on the CSE Under the Ticker "DOSE"
Burlington, Ontario--(Newsfile Corp. - December 17, 2018) - Rapid Dose Therapeutics Corp. (formerly ACME Resources Corp.) (CSE: DOSE) ("RDT" or the "Corporation") is pleased to announce that, following completion of the business combination with Rapid Dose Therapeutics Inc., the Corporation's Common Shares will commence trading on the Canadian Securities Exchange (the "CSE") under the four-letter ticker symbol "DOSE" effective as of the opening of the market today. RDT's CEO, Mark Upsdell,...
2018-12-17 8:15 AM EST
ACME Resources Announces Change of Name to Rapid Dose Therapeutics Corp. and Changes of Directors and Officers
Toronto, Ontario--(Newsfile Corp. - December 10, 2018) - Further to its press release of December 7, 2018, Rapid Dose Therapeutics Corp. (formerly ACME Resources Corp.) ("ACME" or the "Corporation"), is pleased to announce the change of its name from ACME Resources Corp. to Rapid Dose Therapeutics Corp. in connection with the completion of its business combination with Rapid Dose Therapeutics Inc. ("RDT"). In addition, the Corporation welcomes its new board members, Messrs. Mark Upsdell,...
2018-12-10 4:52 PM EST
ACME Resources and Rapid Dose Therapeutics Announce Completion of Amalgamation
Toronto and Burlington, Ontario--(Newsfile Corp. - December 7, 2018) - ACME Resources Corp. ("ACME" or the "Corporation") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to jointly announce the completion of the three-cornered amalgamation pursuant to an Amended and Restated Amalgamation Agreement (the "Amalgamation Agreement") as of July 11, 2018 as further amended (the "Transaction"). As announced in the Corporation's press release of July 12, 2018, ACME entered into the Amalgamation...
2018-12-07 6:22 PM EST
ACME Resources Announces Filing of Final Non-Offering Prospectus
Toronto, Ontario--(Newsfile Corp. - December 6, 2018) - ACME Resources Corp. ("ACME" or the "Corporation") is pleased to announce that it has received a receipt from the Ontario Securities Commission for the filing of its final non-offering long form prospectus. A copy of the prospectus is available under the Corporation's profile on SEDAR (www.sedar.com). The Corporation is also pleased to announce that the Canadian Securities Exchange (the "CSE") has conditionally approved the listing of...
2018-12-06 7:46 PM EST
Rapid Dose Therapeutics Announces Agreement with Chemesis International to License QuickStrip(TM) Technology in Puerto Rico
Toronto and Burlington, Ontario--(Newsfile Corp. - November 7, 2018) - ACME Resources Corp. ("ACME" or the "Company") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT's United States subsidiary, RDT Therapeutics Inc. ("RDT-US"), has signed an additional definitive five-year, renewable Managed Strip Services (MSS) Agreement with Chemesis International Inc. (CSE: CSI) ("Chemesis") for the territory of Puerto Rico. Under the Managed Strip Services Agreement, Chemesis has...
2018-11-07 3:17 PM EST
Rapid Dose Therapeutics Signs an Exclusive Preferred Global Vendor Agreement with Aphria
Burlington, Ontario--(Newsfile Corp. - November 5, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) have signed a definitive agreement granting Aphria exclusive preferred global vendor status for the production and sales of RDT's QuickStrip™ technology for both medicinal and adult-use cannabis markets around the world. RDT's game-changing, proprietary QuickStrip™ technology is a...
2018-11-05 9:31 AM EST
ACME Resources Announces Rapid Dose Therapeutics Wins Top Ten in Grocery Award at Grocery Innovations Canada
Ontario and Burlington, Ontario--(Newsfile Corp. - October 30, 2018) - ACME Resources Corp. ("ACME" or the "Company") and Rapid Dose Therapeutics Inc. ("RDT"), a Canadian bio-technology company focused on providing disruptive proprietary drug delivery technologies for the nutraceutical, therapeutic and pharamecutical market, are pleased to announce that RDT's "QuickStrip™" product won the highly respected "Top Ten in Grocery" award for non-food category at the Grocery Innovations Canada...
2018-10-30 9:20 AM EDT